Search research articles
Contact Us
Filters
Showing results (1021-1030 of 1,096) with videos related to
Page
of 110
Sort By:
Frontiers in Immunology
|
August 12, 2022
Corrigendum: A matter of life or death: Productively infected and bystander CD4 T Cells in early HIV infection
Dechao Cao, Sushant Khanal, Ling Wang, et al.
Frontiers in Immunology
|
November 30, 2019
ATM Deficiency Accelerates DNA Damage, Telomere Erosion, and Premature T Cell Aging in HIV-Infected Individuals on Antiretroviral Therapy
Juan Zhao, Lam Ngoc Thao Nguyen, Lam Nhat Nguyen, et al.
Frontiers in Immunology
|
March 29, 2021
Long Non-coding RNA GAS5 Regulates T Cell Functions via miR21-Mediated Signaling in People Living With HIV
Lam Ngoc Thao Nguyen, Lam Nhat Nguyen, Juan Zhao, et al.
Frontiers in Immunology
|
March 1, 2021
A Matter of Life or Death: Productively Infected and Bystander CD4 T Cells in Early HIV Infection
Dechao Cao, Sushant Khanal, Ling Wang, et al.
Scientific Reports
|
December 17, 2020
LncRNA HOTAIRM1 promotes MDSC expansion and suppressive functions through the HOXA1-miR124 axis during HCV infection
Bal Krishna Chand Thakuri, Jinyu Zhang, Juan Zhao, et al.
Obesity (Silver Spring, Md.)
|
June 11, 2020
What Should I Eat and Why? The Environmental, Genetic, and Behavioral Determinants of Food Choice: Summary from a Pennington Scientific Symposium
Emily Qualls-Creekmore, Kara L Marlatt, Esther Aarts, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 28, 2015
VU0477573: Partial Negative Allosteric Modulator of the Subtype 5 Metabotropic Glutamate Receptor with In Vivo Efficacy
Hilary Highfield Nickols, Joannes P Yuh, Karen J Gregory, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 18, 2011
The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease
Carrie K Jones, Michael Bubser, Analisa D Thompson, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 5, 2013
Heterotropic activation of the midazolam hydroxylase activity of CYP3A by a positive allosteric modulator of mGlu5: in vitro to in vivo translation and potential impact on clinically relevant drug-drug interactions
Anna L Blobaum, Thomas M Bridges, Frank W Byers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 6, 2025
Quantitative Protein Expression of Antibody-Drug Conjugate Targets in EGFR Mutated and Wild-Type Non-Small Cell Lung Cancer
Ioannis P Trontzas, Mengni He, Anna Wurtz, et al.
Page
of 110
Search research articles
Search
Showing results (1021-1030 of 1,096) with videos related to
Sort By:
Page
of 110
Frontiers in Immunology
|
August 12, 2022
Corrigendum: A matter of life or death: Productively infected and bystander CD4 T Cells in early HIV infection
Dechao Cao, Sushant Khanal, Ling Wang, et al.
Frontiers in Immunology
|
November 30, 2019
ATM Deficiency Accelerates DNA Damage, Telomere Erosion, and Premature T Cell Aging in HIV-Infected Individuals on Antiretroviral Therapy
Juan Zhao, Lam Ngoc Thao Nguyen, Lam Nhat Nguyen, et al.
Frontiers in Immunology
|
March 29, 2021
Long Non-coding RNA GAS5 Regulates T Cell Functions via miR21-Mediated Signaling in People Living With HIV
Lam Ngoc Thao Nguyen, Lam Nhat Nguyen, Juan Zhao, et al.
Frontiers in Immunology
|
March 1, 2021
A Matter of Life or Death: Productively Infected and Bystander CD4 T Cells in Early HIV Infection
Dechao Cao, Sushant Khanal, Ling Wang, et al.
Scientific Reports
|
December 17, 2020
LncRNA HOTAIRM1 promotes MDSC expansion and suppressive functions through the HOXA1-miR124 axis during HCV infection
Bal Krishna Chand Thakuri, Jinyu Zhang, Juan Zhao, et al.
Obesity (Silver Spring, Md.)
|
June 11, 2020
What Should I Eat and Why? The Environmental, Genetic, and Behavioral Determinants of Food Choice: Summary from a Pennington Scientific Symposium
Emily Qualls-Creekmore, Kara L Marlatt, Esther Aarts, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 28, 2015
VU0477573: Partial Negative Allosteric Modulator of the Subtype 5 Metabotropic Glutamate Receptor with In Vivo Efficacy
Hilary Highfield Nickols, Joannes P Yuh, Karen J Gregory, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 18, 2011
The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease
Carrie K Jones, Michael Bubser, Analisa D Thompson, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 5, 2013
Heterotropic activation of the midazolam hydroxylase activity of CYP3A by a positive allosteric modulator of mGlu5: in vitro to in vivo translation and potential impact on clinically relevant drug-drug interactions
Anna L Blobaum, Thomas M Bridges, Frank W Byers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 6, 2025
Quantitative Protein Expression of Antibody-Drug Conjugate Targets in EGFR Mutated and Wild-Type Non-Small Cell Lung Cancer
Ioannis P Trontzas, Mengni He, Anna Wurtz, et al.
Page
of 110